Bimzelx was first approved last year for the treatment of moderate to severe psoriasis in adults, making it the first and ...

GeneCQ uses integrated medical and pharmacy claims data to provide insight into the exposure to the costs for gene therapies.

Results looking at the first season of RSV use shows that it is 75% effective at preventing RSV-associated hospitalizations ...

New anecdotal evidence suggests some chemoimmunotherapy treatments may improve pulmonary arterial hypertension symptoms, but the overall evidence remains murky.